24-hour urine collection : split daytime and nightime
https://libcat.nshealth.ca/en/permalink/chpams36496
Nova Scotia Health Authority. Renal Program.
Halifax, NS:
Nova Scotia Health Authority
, 2019.
- Pamphlet Number
- 1940
- Available Online
- View Pamphlet
Step-by-step instructions are provided to collect a 24 hour split urine sample. Locations for drop offs (24 hour access) are included.
- Available Online
- View Pamphlet
- Corporate Author
- Nova Scotia Health Authority. Renal Program
- Place of Publication
- Halifax, NS
- Publisher
- Nova Scotia Health Authority
- Date of Publication
- 2019
- Format
- Pamphlet
- Language
- English
- Physical Description
- 1 electronic document ([2] p.) : digital, PDF file
- Subjects (MeSH)
- Urine Specimen Collection
- Specimen Handling
- Subjects (LCSH)
- Diagnostic specimens
- Urine--Collection and preservation
- Abstract
- Step-by-step instructions are provided to collect a 24 hour split urine sample. Locations for drop offs (24 hour access) are included.
- Responsibility
- Prepared by: NSHA Renal Program
- Pamphlet Number
- 1940
Cefazolin for peritonitis in peritoneal dialysis
https://libcat.nshealth.ca/en/permalink/chpams35860
Nova Scotia Health Authority. Renal Program.
Halifax, NS:
Nova Scotia Health Authority
, 2017.
- Pamphlet Number
- 1818
- Available Online
- View Pamphlet
If you have peritonitis (an infection in your peritoneum), your renal team may tell you to take an antibiotic, such as cefazolin. This pamphlet explains some of the possible side effects of cefazolin, how to give yourself this drug, and how to store this drug. What to do if you have questions and a list of things to remember are also provided.
- Available Online
- View Pamphlet
- Corporate Author
- Nova Scotia Health Authority. Renal Program
- Alternate Title
- Cefazolin for peritonitis in PD
- Place of Publication
- Halifax, NS
- Publisher
- Nova Scotia Health Authority
- Date of Publication
- 2017
- Format
- Pamphlet
- Language
- English
- Physical Description
- 1 electronic document (5 p.) : digital, PDF file
- Subjects (MeSH)
- Medications
- Peritonitis
- Peritoneal Dialysis
- Subjects (LCSH)
- Drugs
- Peritonitis
- Peritoneal dialysis
- Specialty
- Nephrology
- Medications
- Abstract
- If you have peritonitis (an infection in your peritoneum), your renal team may tell you to take an antibiotic, such as cefazolin. This pamphlet explains some of the possible side effects of cefazolin, how to give yourself this drug, and how to store this drug. What to do if you have questions and a list of things to remember are also provided.
- Responsibility
- Prepared by: Renal Program
- Pamphlet Number
- 1818
Ceftazidime for peritonitis in peritoneal dialysis
https://libcat.nshealth.ca/en/permalink/chpams35861
Nova Scotia Health Authority. Renal Program.
Halifax, NS:
Nova Scotia Health Authority
, 2017.
- Pamphlet Number
- 1819
- Available Online
- View Pamphlet
If you have peritonitis (an infection in your peritoneum), your renal team may tell you to take an antibiotic, such as ceftazidime. This pamphlet explains some of the possible side effects of ceftazidime, how to give yourself this drug, and how to store this drug. What to do if you have questions and a list of things to remember are also provided.
- Available Online
- View Pamphlet
- Corporate Author
- Nova Scotia Health Authority. Renal Program
- Alternate Title
- Ceftazidime for peritonitis in PD
- Place of Publication
- Halifax, NS
- Publisher
- Nova Scotia Health Authority
- Date of Publication
- 2017
- Format
- Pamphlet
- Language
- English
- Physical Description
- 1 electronic document (5 p.) : digital, PDF file
- Subjects (MeSH)
- Medications
- Peritonitis
- Peritoneal Dialysis
- Subjects (LCSH)
- Drugs
- Peritonitis
- Peritoneal dialysis
- Specialty
- Nephrology
- Medications
- Abstract
- If you have peritonitis (an infection in your peritoneum), your renal team may tell you to take an antibiotic, such as ceftazidime. This pamphlet explains some of the possible side effects of ceftazidime, how to give yourself this drug, and how to store this drug. What to do if you have questions and a list of things to remember are also provided.
- Responsibility
- Prepared by: Renal Program
- Pamphlet Number
- 1819
Cinacalcet (Sensipar) to treat secondary hyperparathyroidism in chronic kidney disease (CKD)
https://libcat.nshealth.ca/en/permalink/chpams35371
Nova Scotia Health Authority. Renal Program.
Halifax, NS:
Nova Scotia Health Authority
, 2019.
- Pamphlet Number
- 1465
- Available Online
- View Pamphlet
Secondary hyperparathyroidism is a condition that can be caused by kidney disease. It happens when your kidneys can’t filter out waste products the right way. This leads to too much parathyroid hormone in your blood. Cinacalcet (sin-a-KAL-cet) is a medicine used to lower the level of parathyroid hormone in your blood. This will help to balance your calcium and phosphorous levels. Sensipar® is a brand name for cinacalcet. How to take this medicine and what side effects to watch for are reviewed.
- Available Online
- View Pamphlet
- Corporate Author
- Nova Scotia Health Authority. Renal Program
- Place of Publication
- Halifax, NS
- Publisher
- Nova Scotia Health Authority
- Date of Publication
- 2019
- Format
- Pamphlet
- Language
- English
- Physical Description
- 1 electronic document ([4] p.) : digital, PDF file
- Subjects (MeSH)
- Cinacalcet
- Renal Insufficiency, Chronic - drug therapy
- Hyperparathyroidism, Secondary - drug therapy
- Subjects (LCSH)
- Chronic renal failure
- Hyperparathyroidism
- Kidneys--Diseases--Treatment
- Abstract
- Secondary hyperparathyroidism is a condition that can be caused by kidney disease. It happens when your kidneys can’t filter out waste products the right way. This leads to too much parathyroid hormone in your blood. Cinacalcet (sin-a-KAL-cet) is a medicine used to lower the level of parathyroid hormone in your blood. This will help to balance your calcium and phosphorous levels. Sensipar® is a brand name for cinacalcet. How to take this medicine and what side effects to watch for are reviewed.
- Notes
- Previous title: Sensipar (Cinacalcet) to treat secondary hyperparathyroidism in chronic kidney disease
- Responsibility
- Prepared by: NSHA Renal Program
- Pamphlet Number
- 1465
Day surgery peritoneal dialysis catheter insertion
https://libcat.nshealth.ca/en/permalink/chpams35158
Nova Scotia Health Authority. Renal Program.
Halifax, NS:
Nova Scotia Health Authority
, 2019.
- Pamphlet Number
- 1226
- Available Online
- View Pamphlet
This pamphlet reviews what to expect before, during and after surgery for the insertion of a peritoneal dialysis catheter. Information includes how to get your bowels ready for surgery, what to bring to the hospital on the day of surgery, care of your incision/exit site and keeping your bowels regular after surgery. Information about peritoneal dialysis teaching is also provided.
- Available Online
- View Pamphlet
- Corporate Author
- Nova Scotia Health Authority. Renal Program
- Place of Publication
- Halifax, NS
- Publisher
- Nova Scotia Health Authority
- Date of Publication
- 2019
- Format
- Pamphlet
- Language
- English
- Physical Description
- 1 electronic document (18 p.) : digital, PDF file
- Subjects (MeSH)
- Hospital admission
- Peritoneal dialysis
- Kidney Diseases - surgery
- Preoperative Care
- Postoperative Care
- Subjects (LCSH)
- Peritoneal access
- Peritoneal dialysis
- Preoperative care
- Postoperative care
- Specialty
- Nephrology
- Hematology
- Abstract
- This pamphlet reviews what to expect before, during and after surgery for the insertion of a peritoneal dialysis catheter. Information includes how to get your bowels ready for surgery, what to bring to the hospital on the day of surgery, care of your incision/exit site and keeping your bowels regular after surgery. Information about peritoneal dialysis teaching is also provided.
- Responsibility
- prepared by: NSHA Renal Program
- Pamphlet Number
- 1226
Gentamicin or tobramycin for peritonitis in peritoneal dialysis
https://libcat.nshealth.ca/en/permalink/chpams35862
Nova Scotia Health Authority. Renal Program.
Halifax, NS:
Nova Scotia Health Authority
, 2017.
- Pamphlet Number
- 1820
- Available Online
- View Pamphlet
If you have peritonitis (an infection in your peritoneum), your renal team may tell you to take an antibiotic, such as gentamicin or tobramycin. This pamphlet explains some of the possible side effects of gentamicin and tobramycin, how to give yourself these drugs, and how to store these drugs. What to do if you have questions and a list of things to remember are also provided.
- Available Online
- View Pamphlet
- Corporate Author
- Nova Scotia Health Authority. Renal Program
- Alternate Title
- Gentamicin or tobramycin for peritonitis in PD
- Place of Publication
- Halifax, NS
- Publisher
- Nova Scotia Health Authority
- Date of Publication
- 2017
- Format
- Pamphlet
- Language
- English
- Physical Description
- 1 electronic document (5 p.) : digital, PDF file
- Subjects (MeSH)
- Medications
- Peritonitis
- Peritoneal Dialysis
- Subjects (LCSH)
- Drugs
- Peritonitis
- Peritoneal dialysis
- Specialty
- Nephrology
- Medications
- Abstract
- If you have peritonitis (an infection in your peritoneum), your renal team may tell you to take an antibiotic, such as gentamicin or tobramycin. This pamphlet explains some of the possible side effects of gentamicin and tobramycin, how to give yourself these drugs, and how to store these drugs. What to do if you have questions and a list of things to remember are also provided.
- Responsibility
- Prepared by: Renal Program
- Pamphlet Number
- 1820
Heparin to prevent clotting during hemodialysis
https://libcat.nshealth.ca/en/permalink/chpams35407
Nova Scotia Health Authority. Renal Program.
Halifax, NS:
Nova Scotia Health Authority
, 2017.
- Pamphlet Number
- 1494
- Available Online
- View Pamphlet
This pamphlet explains how heparin can help a person with kidney disease who is on hemodialysis. This medicine helps people with kidney disease by preventing blood from clotting in the dialysis lines during hemodialysis. How to take the medicine and what side effects to watch for are reviewed.
- Available Online
- View Pamphlet
- Corporate Author
- Nova Scotia Health Authority. Renal Program
- Place of Publication
- Halifax, NS
- Publisher
- Nova Scotia Health Authority
- Date of Publication
- 2017
- Format
- Pamphlet
- Language
- English
- Physical Description
- 1 electronic document ([4] p.) : digital, PDF file
- Subjects (MeSH)
- Renal Dialysis
- Heparin - therapeutic use
- Anticoagulants - therapeutic use
- Subjects (LCSH)
- Heparin
- Anticoagulants (Medicine)
- Hemodialysis
- Specialty
- Nephrology
- Medications
- Abstract
- This pamphlet explains how heparin can help a person with kidney disease who is on hemodialysis. This medicine helps people with kidney disease by preventing blood from clotting in the dialysis lines during hemodialysis. How to take the medicine and what side effects to watch for are reviewed.
- Responsibility
- Prepared by: Renal Program
- Pamphlet Number
- 1494
Lanthanum (Fosrenol) and chronic kidney disease (CKD)
https://libcat.nshealth.ca/en/permalink/chpams35370
Nova Scotia Health Authority. Renal Program.
Halifax, NS:
Nova Scotia Health Authority
, 2019.
- Pamphlet Number
- 1466
- Available Online
- View Pamphlet
Lanthanum (LAN-tha-num) is a medicine used to treat high levels of phosphorus (a mineral that builds strong bones and teeth) in the body. Lanthanum binds (attaches) to the phosphorus in the foods you eat and stops your body from taking it in. People with kidney disease are less able to remove phosphorus from the body. When phosphorus levels in the blood get too high, it pushes calcium out from your bones. This makes them weaker. Hemodialysis can remove some of the extra phosphorus, but medicin…
- Available Online
- View Pamphlet
- Corporate Author
- Nova Scotia Health Authority. Renal Program
- Place of Publication
- Halifax, NS
- Publisher
- Nova Scotia Health Authority
- Date of Publication
- 2019
- Format
- Pamphlet
- Language
- English
- Physical Description
- 1 electronic document ([4] p.) : digital, PDF file
- Subjects (MeSH)
- Renal Insufficiency, Chronic - drug therapy
- Renal Dialysis
- Lanthanum
- Subjects (LCSH)
- Chronic renal failure
- Kidneys--Diseases--Treatment
- Hemodialysis
- Abstract
- Lanthanum (LAN-tha-num) is a medicine used to treat high levels of phosphorus (a mineral that builds strong bones and teeth) in the body. Lanthanum binds (attaches) to the phosphorus in the foods you eat and stops your body from taking it in. People with kidney disease are less able to remove phosphorus from the body. When phosphorus levels in the blood get too high, it pushes calcium out from your bones. This makes them weaker. Hemodialysis can remove some of the extra phosphorus, but medicines such as lanthanam are often needed to help remove more. How to take the medicine and what side effects to watch for are reviewed. Fosrenol® is a brand name for lanthanum.
- Notes
- Previous title: Fosrenol (Lanthanum) and hemodialysis
- Responsibility
- Prepared by: NSHA Renal Program
- Pamphlet Number
- 1466
Over-the-counter medications & chronic kidney disease
https://libcat.nshealth.ca/en/permalink/chpams35643
Nova Scotia Health Authority. Renal Program.
Halifax, NS:
Nova Scotia Health Authority
, 2019.
- Pamphlet Number
- 1636
- Available Online
- View Pamphlet
If you have chronic kidney disease, you need to be aware of certain over-the-counter medications that are your best choices and those that could cause unpleasant side effects. This pamphlet lists common ailments (e.g., cough and cold, fever or pain, allergies, upset stomach or heartburn, nausea or vomiting, diarrhea, constipation) and over-the-counter medications that are your best choices, their costs, and medications to stay away from. It also lists your best choices for multivitamins, creams…
- Available Online
- View Pamphlet
- Corporate Author
- Nova Scotia Health Authority. Renal Program
- Place of Publication
- Halifax, NS
- Publisher
- Nova Scotia Health Authority
- Date of Publication
- 2019
- Format
- Pamphlet
- Language
- English
- Physical Description
- 1 electronic document ([6] p.) : digital, PDF file
- Subjects (MeSH)
- Nonprescription Drugs
- Renal Insufficiency, Chronic - drug therapy
- Subjects (LCSH)
- Drugs, Nonprescription
- Chronic renal failure
- Specialty
- Medications
- Abstract
- If you have chronic kidney disease, you need to be aware of certain over-the-counter medications that are your best choices and those that could cause unpleasant side effects. This pamphlet lists common ailments (e.g., cough and cold, fever or pain, allergies, upset stomach or heartburn, nausea or vomiting, diarrhea, constipation) and over-the-counter medications that are your best choices, their costs, and medications to stay away from. It also lists your best choices for multivitamins, creams and ointments, and gives information on why herbal products are not recommended.
- Responsibility
- Prepared by: Renal Program
- Pamphlet Number
- 1636
Pneumovax 23 (pneumococcal polyvalent) vaccine and kidney disease
https://libcat.nshealth.ca/en/permalink/chpams36445
Nova Scotia Health Authority. Renal Program.
Halifax, NS:
Nova Scotia Health Authority
, 2018.
- Pamphlet Number
- 1890
- Available Online
- View Pamphlet
Pneumovax® 23 is a vaccine that protects against infections caused by the Streptococcus pneumoniae bacteria. Streptococcus pneumoniae is a type of bacteria that spreads from person to person by droplets when coughing or sneezing.This bacteria can cause many types of infections such as: pneumonia, meningitis, bacteremia, sinusitis, and otitis media. Pneumovax® 23 is recommended for adults with a weakened immune system as a result of kidney disease. Why you may need to get vaccinated, possible si…
- Available Online
- View Pamphlet
- Corporate Author
- Nova Scotia Health Authority. Renal Program
- Place of Publication
- Halifax, NS
- Publisher
- Nova Scotia Health Authority
- Date of Publication
- 2018
- Format
- Pamphlet
- Language
- English
- Physical Description
- 1 electronic document (5 p.) : digital, PDF file
- Subjects (MeSH)
- Pneumococcal Vaccines
- Streptococcus pneumoniae
- Kidney Diseases
- Subjects (LCSH)
- Pneumococcal vaccine
- Streptococcus pneumoniae
- Kidneys--Diseases
- Abstract
- Pneumovax® 23 is a vaccine that protects against infections caused by the Streptococcus pneumoniae bacteria. Streptococcus pneumoniae is a type of bacteria that spreads from person to person by droplets when coughing or sneezing.This bacteria can cause many types of infections such as: pneumonia, meningitis, bacteremia, sinusitis, and otitis media. Pneumovax® 23 is recommended for adults with a weakened immune system as a result of kidney disease. Why you may need to get vaccinated, possible side effects, the 2 types of vaccines, who should not get vaccinated, and when to get each vaccine are reviewed.
- Responsibility
- Prepared by: NSHA Renal Program
- Pamphlet Number
- 1890
Prevnar 13 (pneumococcal conjugate vaccine) and kidney disease
https://libcat.nshealth.ca/en/permalink/chpams36443
Nova Scotia Health Authority. Renal Program.
Halifax, NS:
Nova Scotia Health Authority
, 2018.
- Pamphlet Number
- 1889
- Available Online
- View Pamphlet
Prevnar® 13 is a vaccine that protects against infections caused by the Streptococcus pneumoniae bacteria. Streptococcus pneumoniae is a type of bacteria that spreads from person to person by droplets when coughing or sneezing.This bacteria can cause many types of infections such as: pneumonia, meningitis, bacteremia, sinusitis, and otitis media. Prevnar® 13 is recommended for adults with a weakened immune system as a result of kidney disease. Why you may need to get vaccinated, possible side e…
- Available Online
- View Pamphlet
- Corporate Author
- Nova Scotia Health Authority. Renal Program
- Place of Publication
- Halifax, NS
- Publisher
- Nova Scotia Health Authority
- Date of Publication
- 2018
- Format
- Pamphlet
- Language
- English
- Physical Description
- 1 electronic document (5 p.) : digital, PDF file
- Subjects (LCSH)
- Streptococcus pneumoniae
- Kidneys--Diseases
- Abstract
- Prevnar® 13 is a vaccine that protects against infections caused by the Streptococcus pneumoniae bacteria. Streptococcus pneumoniae is a type of bacteria that spreads from person to person by droplets when coughing or sneezing.This bacteria can cause many types of infections such as: pneumonia, meningitis, bacteremia, sinusitis, and otitis media. Prevnar® 13 is recommended for adults with a weakened immune system as a result of kidney disease. Why you may need to get vaccinated, possible side effects, the 2 types of vaccines, who should not get vaccinated, and when to get each vaccine are reviewed.
- Responsibility
- Prepared by: NSHA Renal Program
- Pamphlet Number
- 1889
Sevelamer (Renagel) and chronic kidney disease (CKD)
https://libcat.nshealth.ca/en/permalink/chpams35372
Nova Scotia Health Authority. Renal Program.
Halifax, NS:
Nova Scotia Health Authority
, 2019.
- Pamphlet Number
- 1464
- Available Online
- View Pamphlet
Sevelamer (se-VEL-a-mer) is a medicine used to treat high levels of phosphorus (a mineral that builds strong bones and teeth) in the body. People with kidney disease are less able to remove phosphorus from their body. When phosphorus levels in the blood get too high, it pushes calcium out from your bones. Hemodialysis can remove some of the extra phosphorus, but medicines such as sevelamer are often needed to help remove more. How to take sevelamer and what side effects to watch for are reviewe…
- Available Online
- View Pamphlet
- Corporate Author
- Nova Scotia Health Authority. Renal Program
- Place of Publication
- Halifax, NS
- Publisher
- Nova Scotia Health Authority
- Date of Publication
- 2019
- Format
- Pamphlet
- Language
- English
- Physical Description
- 1 electronic document ([4] p.) : digital, PDF file
- Subjects (MeSH)
- Sevelamer
- Renal Insufficiency, Chronic - drug therapy
- Renal Dialysis
- Subjects (LCSH)
- Hemodialysis
- Chronic renal failure
- Kidneys--Diseases--Treatment
- Abstract
- Sevelamer (se-VEL-a-mer) is a medicine used to treat high levels of phosphorus (a mineral that builds strong bones and teeth) in the body. People with kidney disease are less able to remove phosphorus from their body. When phosphorus levels in the blood get too high, it pushes calcium out from your bones. Hemodialysis can remove some of the extra phosphorus, but medicines such as sevelamer are often needed to help remove more. How to take sevelamer and what side effects to watch for are reviewed. Renagel® is a brand name for sevelamer.
- Notes
- Previous title: Renagel (Sevelamer) and Hemodialysis
- Responsibility
- Prepared by: NSHA Renal Program
- Pamphlet Number
- 1464
Vancomycin for peritonitis in peritoneal dialysis
https://libcat.nshealth.ca/en/permalink/chpams35863
Nova Scotia Health Authority. Renal Program.
Halifax, NS:
Nova Scotia Health Authority
, 2017.
- Pamphlet Number
- 1821
- Available Online
- View Pamphlet
If you have peritonitis (an infection in your peritoneum), your renal team may tell you to take an antibiotic, such as vancomycin. This pamphlet explains some of the possible side effects of vancomycin, how to give yourself this drug, and how to store this drug. What to do if you have questions and a list of things to remember are also provided.
- Available Online
- View Pamphlet
- Corporate Author
- Nova Scotia Health Authority. Renal Program
- Alternate Title
- Vancomycin for peritonitis in PD
- Place of Publication
- Halifax, NS
- Publisher
- Nova Scotia Health Authority
- Date of Publication
- 2017
- Format
- Pamphlet
- Language
- English
- Physical Description
- 1 electronic document (5 p.) : digital, PDF file
- Subjects (MeSH)
- Medications
- Peritonitis
- Peritoneal Dialysis
- Subjects (LCSH)
- Drugs
- Peritonitis
- Peritoneal dialysis
- Specialty
- Nephrology
- Medications
- Abstract
- If you have peritonitis (an infection in your peritoneum), your renal team may tell you to take an antibiotic, such as vancomycin. This pamphlet explains some of the possible side effects of vancomycin, how to give yourself this drug, and how to store this drug. What to do if you have questions and a list of things to remember are also provided.
- Responsibility
- Prepared by: Renal Program
- Pamphlet Number
- 1821
